support for development (TRL 5/68), deployment and scale-up (TRL 9).

If you can prove that you have sufficient financial means for deployment and scale-up (TRL 9).

Grant and investment

If your innovation still requires significant work to validate and demonstrate in relevant environments to assess its commercial potential.

Grant First

If you are looking to fill the funding gap for rapid scale-up of your high-risk innovation and you don’t need a grant.

• minimum EUR 0.5 million and maximum EUR 15 million,

• usually in the form of direct equity or quasi-equity,

• maximum 25% of the voting shares of the company,

• “patient capital” principle (7-10 years perspective on average).

• maximum EUR 2.5 million,

• eligible costs are reimbursed up to a maximum of 70%,

• innovation activities supported should be completed within 24 months,

• small mid-caps are not eligible for grant (but can apply for investment only).